Blood Transfusion Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Published on : Apr-2020 | List of Tables : 30 | List of Figures : 79 | No. of Pages : 170 | Report Code : FACT4720MR | Format :

Blood Transfusion Diagnostic Market Insights: Rising Patient Pool with Chronic Ailments to Bolster Market Growth

The demand for blood transfusions has experienced an upsurge since the past several years. This is attributed to a large number of patients undergoing surgical procedures for various chronic diseases, such as aplastic anemia, sickle cell anemia and leukemia. This has prompted key players to focus on research & development for advanced instruments, assays and kits in blood banks and hospitals.

The recent COVID-19 pandemic has presented expansion opportunities for blood transfusion diagnostics market. A series of plasma transfusion trials are being conducted in the United States. Practitioners extract the liquid medium from recovered patients and introduce it to infected ones. This “convalescent plasma” is anticipated to boost the immunity of patients battling the disease. On the back of these trends, the global blood transfusion diagnostics market is poised to expand positively at a CAGR of 6.3% during the forecast period (2020-2025).

Application Insights: Molecular-based Disease Screening to Stimulate Market Growth

Molecular-based Disease Screening shall find widespread application of blood transfusion diagnostics, capturing over 70% of the market. This is due to rise in prevalence of Transfusion Transmitted Infections (TTIs) such as Hepatitis C & B and HIV-AIDS. Nucleic Acid Amplification Tests (NAT), based on molecular techniques, has revolutionized the blood diseases screening segment. The disease screening segment is poised to expand at a CAGR of 6.7% in the forecast period.

The blood grouping segment shall expand at a CAGR of 5.6% during the forecast period. Implementation of national blood transfusion policies on blood typing and greater affordability in terms of cost are anticipated to fuel growth. The blood grouping segment is poised to capture more than a quarter of the global blood transfusion diagnostics market in the forecast period.

global blood transfusion diagnostics market 01

To get detailed application insights on the blood transfusion diagnostics market, ask an analyst here

Regional Insights: North America Retains Hegemony, Asia-Pacific Presents Bankable Opportunities

North America is poised to remain the leader in the global blood transfusion diagnostics market. High percentage of voluntary blood donors and implementation of blood transfusion policies for safety and testing for infectious diseases are important growth drivers. The North American market is anticipated to expand at a positive CAGR of 6.4%, capturing over three-tenths of the overall market.

Asia-Pacific is anticipated to grow the fastest, registering a staggering CAGR of 7.0%, capturing greater than two-fifths of the global blood transfusion diagnostics market. This is attributed to high prevalence of TTIs in low-income countries, resulting in greater demand for disease-screening procedures. Moreover, there is a steady increase in the number of blood donation centers and blood donors. There is also an augmented demand for pre-transfusion testing.

global blood transfusion diagnostics market 02

Access our latest regional insights on the global blood transfusion diagnostics market, by requesting for a report sample here

Technological Insights: Plasma Fractionation Key Technological Development of Market Players

The global blood transfusion diagnostics market is semi-consolidated, consisting of the following prominent market players: Grifols S.A., Bio-Rad Laboratories, Inc., Immucor, Inc., CSL Ltd., Abbott Laboratories, and DiaSorin S.p.A. These market players concentrate on introducing technological advancements in testing procedures. An example of such technological development is plasma fractionation.

CSL Ltd., is a major player in the plasma fractionation industry. The company collected an estimated 9 million liters of plasma in 2016. In this technique, various components such as immunoglobulins, albumin and other proteins are extracted for several treatment procedures.

Likewise, Grifols S.A also specializes in plasma fractionation techniques. It manufactures plasma derived products for treating various conditions, such as coagulation disorders, pulmonary disorders, immunodeficiencies and shock and trauma. Its products include the BloodChip multiplex blood group genotyping kit based on Luminex technology for the main allelic variants of red blood cells and human platelet antigens.

COVID-19 Market Insights:

COVID-19 is presently the biggest threat to the health and well-being of citizens across the world. Although there is a dearth of specific antiviral agents for its treatment, feasibility studies are underway to determine possible cures. For example, research is being conducted on convalescent plasma transfusion (CP) and its potential to rescue severely ill patients. Results from 10 severe patients showed that one dose of 200 milliliters of CP could significantly increase or maintain neutralizing antibodies at high levels. CP therapy is a classic adaptive immunotherapy which has been applied for over a century. The therapy was also used to treat SARS, MERS and the H1N1 epidemic in 2009 with satisfactory results. Banking on these trends, medical practitioners anticipate to contain the COVID-19 pandemic as well.

The COVID-19 virus especially presents potent challenges to patients with hemoglobin disorders. Though there is no direct link between respiratory conditions and hemoglobin disorders, complications involving the heart, lungs and the immune system, may be present in these patients. A viral infection can only compound the complications. In addition, these patients may be splenectomised and sickle cell patients may be functionally asplenic. Therefore, taking preventive measures for such patients is a major responsibility of medical caregivers. Key market players, notably CSL Behring, are undertaking unprecedented research to develop a potential plasma therapy to treat COVID-19. CSL is part of an alliance developing one, unbranded anti-SARS-CoV-2 polyclonal hyperimmune immunoglobin medicine. The alliance also seeks to support national governments in their efforts to fight the current pandemic.

Analyst’s Viewpoint:

The global blood transfusion diagnostics market is poised to grow positively during the forecast period. Expansion of the market is based on increasing number of surgical procedures for testing of chronic ailments. Research and development of convalescent plasma (CP) transfusion techniques to boost immunity of patients in the wake of the COVID-19 pandemic is also anticipated to boost market prospects.

Global Blood Transfusion Diagnostics Market: Scope of the Report:

The recent global blood transfusion diagnostics market report by Fact.MR offers a 5-year forecast from 2020 to 2025. The report elaborates on the key drivers, restraints, opportunities and threats to the expansion of the global blood transfusion diagnostics market. A detailed segmental analysis, based on product type, application and end-user, has been provided in the report.

Regional analysis in terms of supply chain analysis, business execution and market value analysis provides an in-depth perspective about the future scope of the global blood transfusion diagnostics market. In addition, a separate section on market structure has also been provided. The section provides a detailed analysis of key market players and the strategies for expansion in the blood transfusion diagnostics market.

Blood Transfusion Diagnostics Market- Scope of the Report

The recent study by Fact.MR on blood transfusion diagnostics market offers a 5-year forecast between 2020 and 2025. The study analyzes crucial trends that are currently determining the growth of blood transfusion diagnostics market. This report explicates on vital dynamics such as the drivers, restraints and opportunities for key market players along with key stakeholders as well as emerging players associated with the provision of blood transfusion diagnostics. The study also provides dynamics responsible for influencing future status of the blood transfusion diagnostics market over the forecast period.

A detailed assessment of blood transfusion diagnostics market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the blood transfusion diagnostics market along with their product portfolio enhances the reliability of this comprehensive research study.

Blood Transfusion Diagnostics Market: Report Summary

The study offers a comprehensive analysis on diverse features including production capacities, demand, product developments, revenue generation and sales in blood transfusion diagnostics market across the globe.

A comprehensive estimate of blood transfusion diagnostics market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of blood transfusion diagnostics market during the forecast period. Price point comparison by region with global average price is also considered in the study.

Blood Transfusion Diagnostics: Market Segmentation

Fact.MR has studied the blood transfusion diagnostics market with detailed segmentation on the basis of product type, application, end-user and geography.

Product Type

Application

End-user

Geography

Instruments

Blood Grouping

Hospitals

North America

Kits & Reagents

Disease Screening:

Molecular Disease Screening

Serological Disease Screening

Diagnostic Laboratories

Europe

 

 

Blood Banks

Asia Pacific

 

 

Plasma Fractionation Companies

Eastern Europe

 

 

Others

Latin America

 

 

 

Middle East & Africa (MEA)

“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than addressee(s) is unauthorized and prohibited.”

Blood Transfusion Diagnostics Market: Analysis on Market Size Evaluation

Blood transfusion diagnostics market has been analyzed for each market segment, in terms of value (US$ Mn).

Market estimates at global and regional levels for blood transfusion diagnostics is available in terms of “US$ Mn” for value. A Y-o-Y growth contrast on prominent blood transfusion diagnostics market segments, along with market attractiveness evaluation, has been incorporated in the report.

Blood Transfusion Diagnostics Market: Inspected Assessment on Regional Segments

Key sections have been elaborated in the blood transfusion diagnostics report, which have helped deliver projection on the regional markets. These chapters include the regional macros (economic, and business environment outlook), which are expected to have a momentous influence on the growth of the blood transfusion diagnostics market during the forecast period.

Country-specific valuation on demand for blood transfusion diagnostics has been offered for each regional market, along with the market scope estimate and forecast, price index, and impact analysis of dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for emerging countries has also been included in the report.

Blood Transfusion Diagnostics Market: In-Depth Analysis on Competitive Landscape

The report sheds light on the leading providers of blood transfusion diagnostics along with their detailed profiles. Essential and up-to-date data information related to the market performers, who are principally engaged in the production of blood transfusion diagnostics, has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits the report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which includes essentials such as product portfolio, key strategies along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through the matrix for all the prominent players thus providing the readers with actionable insights, which helps in thoughtfully presenting market status, and predicting the competition level in the blood transfusion diagnostics market. Prominent manufacturers with established market presence in global blood transfusion diagnostics market are Grifols S.A., Bio-Rad Laboratories, Inc., Immucor, Inc., Abbott Laboratories, and DiaSorin S.p.A. 

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Transfusion Diagnostics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, 2020–2025

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Spend For Plasma Testing For Infectious Diseases (US$ Mn), by Plasma Fractionation Companies, 2015

6. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Product Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2020–2025

        6.3.1. Instruments 

        6.3.2. Kits & Reagents 

    6.4. Market Attractiveness, by Product Type 

7. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Application 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2020–2025

        7.3.1. Blood Grouping

        7.3.2. Disease Screening 

            7.3.2.1. Serological Disease Screening 

            7.3.2.2. Molecular Disease Screening 

    7.4. Market Attractiveness, by Application 

8. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by End-user 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2020–2025

        8.3.1. Hospitals 

        8.3.2. Blood Banks

        8.3.3. Diagnostic Laboratories

        8.3.4. Plasma Fractionation Companies

        8.3.5. Others

    8.4. Market Attractiveness, by End-user 

9. Global Blood Transfusion Diagnostics Market Analysis and Forecasts, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness, by Region

10. North America Blood Transfusion Diagnostics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Product Type, 2020–2025

        10.2.1. Instruments 

        10.2.2. Kits & Reagents 

    10.3. Market Value Forecast, by Application, 2020–2025

        10.3.1. Blood Grouping 

        10.3.2. Disease Screening

            10.3.2.1. Serological Disease Screening 

            10.3.2.2. Molecular Disease Screening 

    10.4. Market Value Forecast, by End-user, 2020–2025

        10.4.1. Hospitals 

        10.4.2. Blood Banks

        10.4.3. Diagnostic Laboratories

        10.4.4. Plasma Fractionation Companies

        10.4.5. Others

    10.5. Market Value Forecast, by Country, 2020–2025

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis 

        10.6.1. By Product Type 

        10.6.2. By Application 

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product Type, 2020–2025

        11.2.1. Instruments 

        11.2.2. Kits & Reagents 

    11.3. Market Value Forecast, by Application, 2020–2025

        11.3.1. Blood Grouping 

        11.3.2. Disease Screening 

            11.3.2.1. Serological Disease Screening 

            11.3.2.2. Molecular Disease Screening 

    11.4. Market Value Forecast, by End-user, 2020–2025

        11.4.1. Hospitals 

        11.4.2. Blood Banks

        11.4.3. Diagnostic Laboratories

        11.4.4. Plasma Fractionation Companies

        11.4.5. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2020–2025

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis 

        11.6.1. By Product Type 

        11.6.2. By Application 

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product Type, 2020–2025

        12.2.1. Instruments 

        12.2.2. Kits & Reagents 

    12.3. Market Value Forecast, by Application, 2020–2025

        12.3.1. Blood Grouping 

        12.3.2. Disease Screening 

            12.3.2.1. Serological Disease Screening 

            12.3.2.2. Molecular Disease Screening 

    12.4. Market Value Forecast, by End-user, 2020–2025

        12.4.1. Hospitals 

        12.4.2. Blood Banks

        12.4.3. Diagnostic Laboratories

        12.4.4. Plasma Fractionation Companies

        12.4.5. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2020–2025

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis 

        12.6.1. By Product Type 

        12.6.2. By Application 

        12.6.3. By End-user 

        12.6.4. By Country/Sub-region

13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product Type, 2020–2025

        13.2.1. Instruments 

        13.2.2. Kits & Reagents 

    13.3. Market Value Forecast, by Application, 2020–2025

        13.3.1. Blood Grouping

        13.3.2. Disease Screening 

            13.3.2.1. Serological Disease Screening 

            13.3.2.2. Molecular Disease Screening 

    13.4. Market Value Forecast, by End-user, 2020–2025

        13.4.1. Hospitals 

        13.4.2. Blood Banks

        13.4.3. Diagnostic Laboratories

        13.4.4. Plasma Fractionation Companies

        13.4.5. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2020–2025

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis 

        13.6.1. By Product Type 

        13.6.2. By Application

        13.6.3. By End-user 

        13.6.4. By Country/Sub-region

14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product Type, 2020–2025

        14.2.1. Instruments 

        14.2.2. Kits & Reagents 

    14.3. Market Value Forecast, by Application, 2020–2025

        14.3.1. Blood Grouping 

        14.3.2. Disease Screening 

            14.3.2.1. Serological Disease Screening 

            14.3.2.2. Molecular Disease Screening 

    14.4. Market Value Forecast, by End-user, 2020–2025

        14.4.1. Hospitals 

        14.4.2. Blood Banks

        14.4.3. Diagnostic Laboratories

        14.4.4. Plasma Fractionation Companies

        14.4.5. Others

    14.5. Market Value Forecast, by Country/Sub-region, 2020–2025

        14.5.1. Saudi Arabia

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis 

        14.6.1. By Product Type 

        14.6.2. By Application 

        14.6.3. By End-user 

        14.6.4. By Country/Sub-region

15. Company Profiles

    15.1. Market Player - Competition Matrix (By Tier and Size of companies)

    15.2. Market Share Analysis, by Company, 2020 (estimated)

    15.3. Company Profiles

        15.3.1. Grifols S.A.

            15.3.1.1. Company Details

            15.3.1.2. Business Overview

            15.3.1.3. Financial Overview

            15.3.1.4. Strategic Overview

            15.3.1.5. SWOT Analysis

        15.3.2. Immucor, Inc.

            15.3.2.1. Company Details

            15.3.2.2. Business Overview

            15.3.2.3. Financial Overview

            15.3.2.4. Strategic Overview

            15.3.2.5. SWOT Analysis

        15.3.3. Ortho Clinical Diagnostics

            15.3.3.1. Company Details

            15.3.3.2. Business Overview

            15.3.3.3. Financial Overview

            15.3.3.4. Strategic Overview

            15.3.3.5. SWOT Analysis

        15.3.4. Abbott

            15.3.4.1. Company Details

            15.3.4.2. Business Overview

            15.3.4.3. Financial Overview

            15.3.4.4. Strategic Overview

            15.3.4.5. SWOT Analysis

        15.3.5. Bio-Rad Laboratories, Inc.

            15.3.5.1. Company Details

            15.3.5.2. Business Overview

            15.3.5.3. Financial Overview

            15.3.5.4. Strategic Overview

            15.3.5.5. SWOT Analysis

        15.3.6. F. Hoffman-La Roche Ltd. 

            15.3.6.1. Company Details

            15.3.6.2. Business Overview

            15.3.6.3. Financial Overview

            15.3.6.4. Strategic Overview

            15.3.6.5. SWOT Analysis

        15.3.7. QUOTIENT LIMITED

            15.3.7.1. Company Details

            15.3.7.2. Business Overview

            15.3.7.3. Financial Overview

            15.3.7.4. Strategic Overview

            15.3.7.5. SWOT Analysis

        15.3.8. BAG Healthcare GmBH 

            15.3.8.1. Company Details

            15.3.8.2. Business Overview

            15.3.8.3. Financial Overview

            15.3.8.4. Strategic Overview

            15.3.8.5. SWOT Analysis

        15.3.9. DiaSorin S.p.A.

            15.3.9.1. Company Details

            15.3.9.2. Business Overview

            15.3.9.3. Financial Overview

            15.3.9.4. Strategic Overview

            15.3.9.5. SWOT Analysis

        15.3.10. Hologic, Inc.

            15.3.10.1. Company Details

            15.3.10.2. Business Overview

            15.3.10.3. Financial Overview

            15.3.10.4. Strategic Overview

            15.3.10.5. SWOT Analysis

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Blood Transfusion Diagnostics Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025